BRF S.A.

Good morning, ladies and gentlemen. Welcome to MBRF's teleconference for the discussion of the results of the second quarter of the year 2026. This teleconference is being recorded and replay can be accessed on the company's website at ri.mbrf.com. The presentation is also available for download. At this moment, all participants are connected only as listeners, and then we will start the Q&A session when more instructions are provided. Before proceeding, I would like to emphasize that the prospective statements are based on the beliefs and assumptions of the administration of the MBRF and the current information available to the company. These statements can involve risks and uncertainties, given that they concern future events and, therefore, depend on circumstances that may or may not occur. Investors, analysts and journalists must take into account that events related to the macroeconomic environment, the segment and other factors can make the results materially different from those expressed in the respective prospective statements. Mr. Miguel Gularte , Mr. Tim Klein and José Inácio Escoceria are present at this teleconference. I would now like to give the floor to Mr. Miguel, who will begin the presentation. Please, Mr. Miguel, you may proceed.

Good morning. Welcome to the MBRF conference for the presentation of the consolidated results of the second quarter of 2026. We ended the period with consistent performance and sales volume record for the second quarter, reflecting the assertiveness of our strategy and discipline in execution in all operations. The liquid revenue reached R$ 40.7 billion in the quarter, a growth of 4.9% in relation to the same period of the previous year. EBITDA totalized R$ 3.2 billion, an evolution of 5.4% with a margin of 7.9%. The recorded liquid profit was R$ 69 million, demonstrating our ability to generate consistent results even in a challenging macroeconomic environment. We continue to advance with our multiprotein platform, strengthening our operations, expanding our presence in the markets in which we operate and expanding the supply of products of greater aggregate value. These movements help to sustain our value generation and prepare the company for long-term growth. Now, to detail the results of the quarter, I pass the floor to our CFO José Inácio Escoceria and I will return to the final considerations.

Good morning everyone. We will continue to comment on the consolidated results of the second quarter of 2026, which contemplates the segments of businesses BIFA América do Norte, BIFA América do Sul and BRF. I highlight that in this second quarter we reported 40.7 billion reais of consolidated liquid revenue. The consolidated adjusted EBITDA was 3.2 billion reais with a consolidated margin of 7.9%. The liquid profit, by the way, was 69 million reais in the quarter. and the reported operating cash flow was R$ 2.2 billion. And finally, we closed the quarter with an increase of 3.41 times the adjusted value of the last 12 months. In the next slide on the left, we present the evolution of volume, liquid revenue and total value and by segment in the year-on-year comparison. We observed growth in all metrics, with highlights for the volumes of the BIF operations. The BIF America do Norte segment contributed 46%, BRF 38% and BIF America do Sul 16% of the total revenue reported in the period. The adjusted EBITDA was 3.2 billion, with a margin of 7.9%, with BRF representing 79%, South America 17% and North America 4%. It is worth mentioning that the captures of the fusion synergies contributed to the reduction of 13% in the comparison II.3.26 vs. II.3.25 of the company's consolidated administrative expenses. In currency terms, 72% of our consolidated revenue is generated in dollars and 28% in reals and other currencies. Strengthening the geographical diversification and the multi-protein portfolio of the company, we presented the breakdown of the revenue, with 45% coming from the United States, 23% from Brazil and the remaining distributed mainly between Asia, the Middle East and Europe, with approximately 40% of the volume of sales from processed products with added value. We will now present the performance by business segment. I give the floor to Team Klein, who will comment on the results of Operation America do Norte.